Biomarkers

Biomarkers still become progressively relevant in analysis and care applications, as proven by the worldwide marketplace for product concerned in their identification, validation, and use calculable at $8.3 billion in 2007 and projected to extend to $15 billion in 2010. AACR, in partnership with the Food and Drug Administration (FDA) and National Cancer Institute (NCI), shaped the AACR-FDA-NCI Cancer Biomarkers cooperative (CBC) to accelerate the interpretation of cancer medicine into the clinic by shaping the processes for the effective development of valid biomarkers and their use in clinical trials for optimum patient profit.

 

 

 

 

<p justify;"="">

    Related Conference of Biomarkers

    November 26-27, 2019

    International Conference On Genomics and Molecular Biology

    Lisbon, Portugal | Holiday Inn Lisbon-Continental Rua Laura Alves 9, 1069-169 Lisboa, Portugal
    November 26-27, 2019

    International Conference on Cell and Gene Therapy

    Lisbon, Portugal | Holiday Inn Lisbon-Continental Rua Laura Alves 9, 1069-169 Lisboa, Portugal
    February 24-25, 2020

    24th Global Congress on Biotechnology

    London, UK
    July 15-16, 2020

    12th World Congress and Expo on Stem Cell Research

    Prague, Czech Republic
    December 07- 08, 2020

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia

    Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in